StockNews.com Begins Coverage on Cara Therapeutics (NASDAQ:CARA)
Equities researchers at StockNews.com assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Cara Therapeutics Price Performance The stock has a market cap of $24.33 million, a PE ratio of -0.25 and a […]
24 Apr 01:50 · The Cerbat Gem